tiprankstipranks
Corcept Therapeutics (CORT)
NASDAQ:CORT
US Market
CORT
Corcept Therapeutics
RESEARCH TOOLSreports
Want to see CORT full AI Analyst Report?

Corcept Therapeutics (CORT) Income Statement

1,301 Followers

Corcept Therapeutics Income Statement

Last quarter (Q1 2026), Corcept Therapeutics's total revenue was $164.90M, an increase of 4.89% from the same quarter last year. In Q1, Corcept Therapeutics's net income was $-31.20M. See Corcept Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 761.41M$ 675.04M$ 482.38M$ 401.86M$ 365.98M
Gross Profit
$ 748.43M$ 664.16M$ 475.89M$ 396.47M$ 360.70M
Operating Expenses
$ 703.63M$ 527.21M$ 368.61M$ 283.84M$ 236.22M
Depreciation and Amortization
$ 1.89M$ 1.34M$ 1.04M$ 1.26M$ 3.07M
EBITDA
$ 46.69M$ 138.29M$ 108.32M$ 113.89M$ 127.95M
Operating Income
$ 44.80M$ 136.95M$ 107.28M$ 112.63M$ 124.48M
Other Income/Expenses
$ 21.67M$ 24.54M$ 17.27M$ 3.56M$ 529.00K
Pretax Income
$ 66.46M$ 161.49M$ 124.56M$ 116.19M$ 125.01M
Net Income
$ 99.65M$ 139.73M$ 106.14M$ 101.42M$ 112.51M
Per Share Metrics
Basic EPS
$ 0.95$ 1.35$ 1.02$ 0.95$ 0.97
Diluted EPS
$ 0.82$ 1.23$ 0.94$ 0.87$ 0.89
Weighted Average Shares Outstanding
 103.86M 103.23M 103.56M 106.79M 115.65M
Weighted Average Shares Outstanding (Diluted)
 119.99M 113.48M 111.74M 115.97M 125.96M
Currency in USD

Corcept Therapeutics Earnings and Revenue History